BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32035130)

  • 21. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
    Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR
    J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma.
    Armeanu S; Krusch M; Baltz KM; Weiss TS; Smirnow I; Steinle A; Lauer UM; Bitzer M; Salih HR
    Clin Cancer Res; 2008 Jun; 14(11):3520-8. PubMed ID: 18519785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma.
    Kohga K; Tatsumi T; Takehara T; Tsunematsu H; Shimizu S; Yamamoto M; Sasakawa A; Miyagi T; Hayashi N
    J Hepatol; 2010 Jun; 52(6):872-9. PubMed ID: 20395004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
    Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
    Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
    Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
    Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scorpion venom activates natural killer cells in hepatocellular carcinoma via the NKG2D-MICA pathway.
    Chen H; Zhidan W; Xia R; Zhaoxia W; Qing J; Qiang G; Haipeng Y; Hengxiao W
    Int Immunopharmacol; 2016 Jun; 35():307-314. PubMed ID: 27089390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.
    Shin S; Kim M; Lee SJ; Park KS; Lee CH
    Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
    Armeanu S; Bitzer M; Lauer UM; Venturelli S; Pathil A; Krusch M; Kaiser S; Jobst J; Smirnow I; Wagner A; Steinle A; Salih HR
    Cancer Res; 2005 Jul; 65(14):6321-9. PubMed ID: 16024634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding.
    Arai J; Goto K; Otoyama Y; Nakajima Y; Sugiura I; Kajiwara A; Tojo M; Ichikawa Y; Uozumi S; Shimozuma Y; Uchikoshi M; Sakaki M; Nozawa H; Nakagawa R; Muroyama R; Kato N; Yoshida H
    Cancer Immunol Immunother; 2021 Jan; 70(1):203-213. PubMed ID: 32683508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells.
    Arai J; Goto K; Tanoue Y; Ito S; Muroyama R; Matsubara Y; Nakagawa R; Kaise Y; Lim LA; Yoshida H; Kato N
    Int J Cancer; 2018 Nov; 143(10):2575-2583. PubMed ID: 29873070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of photodynamic therapy on tumor cell expression of major histocompatibility complex (MHC) class I and MHC class I-related molecules.
    Belicha-Villanueva A; Riddell J; Bangia N; Gollnick SO
    Lasers Surg Med; 2012 Jan; 44(1):60-8. PubMed ID: 22246985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBV suppresses expression of MICA/B on hepatoma cells through up-regulation of transcription factors GATA2 and GATA3 to escape from NK cell surveillance.
    Guan Y; Li W; Hou Z; Han Q; Lan P; Zhang J; Tian Z; Zhang C
    Oncotarget; 2016 Aug; 7(35):56107-56119. PubMed ID: 27528231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells.
    Wu J; Zhang XJ; Shi KQ; Chen YP; Ren YF; Song YJ; Li G; Xue YF; Fang YX; Deng ZJ; Xu X; Gao J; Tang KF
    Carcinogenesis; 2014 Jan; 35(1):155-63. PubMed ID: 23917076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD80 transfected human hepatocellular carcinoma cells activate cytotoxic T lymphocytes to target HCC cells with shared tumor antigens.
    Chan RC; Xie Y
    Oncol Rep; 2004 Aug; 12(2):435-42. PubMed ID: 15254713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association study.
    Goto K; Annan DA; Morita T; Li W; Muroyama R; Matsubara Y; Ito S; Nakagawa R; Tanoue Y; Jinushi M; Kato N
    Sci Rep; 2016 Dec; 6():38407. PubMed ID: 27910927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.
    Sun L; Guo H; Jiang R; Lu L; Liu T; He X
    Tumour Biol; 2016 Jan; 37(1):799-806. PubMed ID: 26250457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.
    Okita R; Mougiakakos D; Ando T; Mao Y; Sarhan D; Wennerberg E; Seliger B; Lundqvist A; Mimura K; Kiessling R
    J Immunol; 2012 Mar; 188(5):2136-45. PubMed ID: 22301547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxia-inducible gene 2 promotes the immune escape of hepatocellular carcinoma from nature killer cells through the interleukin-10-STAT3 signaling pathway.
    Cui C; Fu K; Yang L; Wu S; Cen Z; Meng X; Huang Q; Xie Z
    J Exp Clin Cancer Res; 2019 May; 38(1):229. PubMed ID: 31142329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway.
    Duan Q; Li H; Gao C; Zhao H; Wu S; Wu H; Wang C; Shen Q; Yin T
    J Exp Clin Cancer Res; 2019 May; 38(1):192. PubMed ID: 31088566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.